U.S. markets closed
  • S&P 500

    3,901.82
    +90.67 (+2.38%)
     
  • Dow 30

    31,535.51
    +603.14 (+1.95%)
     
  • Nasdaq

    13,588.83
    +396.48 (+3.01%)
     
  • Russell 2000

    2,275.32
    +74.27 (+3.37%)
     
  • Crude Oil

    60.29
    -0.35 (-0.58%)
     
  • Gold

    1,721.90
    -1.10 (-0.06%)
     
  • Silver

    26.59
    -0.09 (-0.33%)
     
  • EUR/USD

    1.2053
    -0.0035 (-0.29%)
     
  • 10-Yr Bond

    1.4460
    -0.0140 (-0.96%)
     
  • GBP/USD

    1.3929
    +0.0007 (+0.05%)
     
  • USD/JPY

    106.8030
    +0.3010 (+0.28%)
     
  • BTC-USD

    49,577.48
    +4,553.43 (+10.11%)
     
  • CMC Crypto 200

    982.63
    +54.40 (+5.86%)
     
  • FTSE 100

    6,588.53
    +105.10 (+1.62%)
     
  • Nikkei 225

    29,663.50
    +697.49 (+2.41%)
     

Wolf Popper LLP Announces Investigation on Behalf of Investors in Clover Health Investments, Corp. (CLOV)

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, Feb. 5, 2021 /PRNewswire/ -- Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of Clover Health Investments, Corp. (NASDAQ: CLOV).

On April 21, 2020, a blank check/special purpose acquisition vehicle called Social Capital Hedosophia Holdings Corp. III ("SCH") had its IPO. SCH's securities were listed and traded under the symbols IPOC, IPOC.WS, and IPOC.U. On October 6, 2020, SCH announced it was going to merge with Clover Health Investments Corp. in a deal that valued Clover at a $3.7B enterprise value. The deal closed on January 7, 2021 and the company changed its name to Clover Health Investments, Corp. and its stock symbol to "CLOV".

On February 4, 2021, Hindenburg Research issued a report alleging that Clover was "under active investigation by the Department of Justice (DOJ), which is investigating at least 12 issues ranging from kickbacks to marketing practices to undisclosed third-party deals, according to a Civil Investigative Demand (similar to a subpoena) [Hindenburg] obtained."

On this news, Clover's stock price fell over 12% and closed at $12.23 per share on February 4, 2021.

On February 5, 2021, Clover announced that it had "received a letter from the [SEC] indicating that it is conducting an investigation and requesting document and data preservation for the period from January 1, 2020, to the present, relating to certain matters that are referenced in the [Hindenburg] article.

SCH and Clover investors who would like to discuss our investigation should contact Joshua Ruthizer at (212) 451-9668 or (877) 370-7703 or at jruthizer@wolfpopper.com.

Wolf Popper has successfully recovered billions of dollars for defrauded investors. Wolf Popper's reputation and expertise have been repeatedly recognized by the courts, which have appointed the firm to major positions in securities litigation. For more information about Wolf Popper, please visit the Firm's website at www.wolfpopper.com.

Attorney Advertising: Prior Results Do Not Guarantee A Similar Outcome.

Wolf Popper LLP

Joshua W. Ruthizer
845 Third Avenue
New York, NY 10022
Tel.: (212) 451-9668
Tel.: (877) 370-7703
Fax: (877) 370-7704
Email: jruthizer@wolfpopper.com

Cision
Cision

View original content:http://www.prnewswire.com/news-releases/wolf-popper-llp-announces-investigation-on-behalf-of-investors-in-clover-health-investments-corp-clov-301223278.html

SOURCE Wolf Popper LLP